trial
as of 2026-07-01The Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia
NCTId NCT05957484
at a glance
— · Terminated
Enrollment 4 (actual)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2025-02-11
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Terminated
Enrollment
4 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2023-09-12
Primary completion
2025-02-11
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
Scion NeuroStimCollaborator
Investigators
1
Philip Gerretsen, MD, PhDPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
4
Phase
NA
Primary Completion Date
2025-02-11
Status
TERMINATED
relationships
The graph out of here
lead_sponsor
collaborator
company
indication
investigator